Variant report
Variant | esv3434869 |
---|---|
Chromosome Location | chr5:68117677-68121030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534534381 | chr5:68117712-68117713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73121033 | chr5:68117744-68117745 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs538728461 | chr5:68117758-68117759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537910059 | chr5:68117776-68117777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568212862 | chr5:68117799-68117800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574880277 | chr5:68117836-68117837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535433361 | chr5:68117925-68117926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553783697 | chr5:68117926-68117927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185960254 | chr5:68117936-68117937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572765161 | chr5:68117937-68117938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561405884 | chr5:68117975-68117976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16898225 | chr5:68118029-68118030 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs76454423 | chr5:68118043-68118044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557361792 | chr5:68118182-68118183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144126349 | chr5:68118210-68118211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1427905 | chr5:68118222-68118223 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs562600982 | chr5:68118262-68118263 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369859589 | chr5:68118303-68118304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529844910 | chr5:68118319-68118320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192114966 | chr5:68118325-68118326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560207783 | chr5:68118357-68118358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527965018 | chr5:68118390-68118391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552841027 | chr5:68118423-68118424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371672273 | chr5:68118452-68118453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553735072 | chr5:68118464-68118465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183991648 | chr5:68118476-68118477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs199983002 | chr5:68118510-68118511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200621150 | chr5:68118511-68118512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201074107 | chr5:68118513-68118514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550133052 | chr5:68118529-68118530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568523429 | chr5:68118613-68118614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114014218 | chr5:68118622-68118623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186533199 | chr5:68118639-68118640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539693930 | chr5:68118652-68118653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572110088 | chr5:68118662-68118663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141835850 | chr5:68118665-68118666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190581228 | chr5:68118694-68118695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150604744 | chr5:68118696-68118697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544374418 | chr5:68118699-68118700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575541310 | chr5:68118726-68118727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139780644 | chr5:68118809-68118810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201572834 | chr5:68118862-68118863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112909647 | chr5:68118863-68118864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560145509 | chr5:68118867-68118868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369363895 | chr5:68118896-68118897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551930134 | chr5:68118916-68118917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564777591 | chr5:68118936-68118937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531945098 | chr5:68118950-68118951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372942836 | chr5:68118973-68118974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550314552 | chr5:68119032-68119033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Lung cancer | 17086460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68115200-68118600 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr5:68115400-68118200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr5:68117400-68118600 | Weak transcription | Brain Hippocampus Middle | brain |
4 | chr5:68117400-68118600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
5 | chr5:68117400-68118600 | Weak transcription | Brain Substantia Nigra | brain |
6 | chr5:68118200-68118800 | Enhancers | Fetal Kidney | kidney |
7 | chr5:68118200-68119200 | Enhancers | HepG2 | liver |
8 | chr5:68118200-68120200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr5:68118600-68118800 | Enhancers | Brain Inferior Temporal Lobe | brain |
10 | chr5:68118600-68119000 | Enhancers | Brain Angular Gyrus | brain |
11 | chr5:68118600-68119000 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr5:68118600-68119000 | Enhancers | Brain Substantia Nigra | brain |
13 | chr5:68118800-68119800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr5:68119200-68119600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr5:68119400-68119800 | Enhancers | Adipose Nuclei | Adipose |